{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T22:00:53Z","timestamp":1793397653542,"version":"4.5.0"},"reference-count":47,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,4,25]],"date-time":"2025-04-25T00:00:00Z","timestamp":1745539200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Psychol."],"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Considering the increasing evidence supporting psilocybin\u2019s efficacy in therapeutic settings, it is essential to deepen our understanding of its subjective meanings and effects to enhance its integration into psychotherapy. Current knowledge is primarily based on psychometric assessments or unstructured personal reports, leaving a gap in the qualitative analysis of subjective psychedelic experiences and the resulting changes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>\n                      This study aimed to describe the subjective psychedelic experience with psilocybin in a structured, objective, and non-judgmental way (\n                      <jats:italic>Epoche<\/jats:italic>\n                      ), while exploring its potential clinical applications.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A phenomenological qualitative approach, integrating interpretative phenomenological analysis (IPA) and the dynamic analysis (PHD) method, was used to analyze self-reported psilocybin experiences. Participants who met the inclusion criteria of being healthy adults and who had experienced psilocybin without any other substances were recruited through convenience sampling. Semi-structured interviews explored dimensions such as emotions, bodily sensations, perception of time and space, relationships, values, and enduring transformation. Data were analyzed using thematic coding.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Ten interviews were carried out with voluntary participants. All the interviewees reported enhanced emotional and interpersonal sensitivity, increased empathy, a deeper connection to others, and a heightened ability to resolve personal issues as well as long-lasting insights into their lives and values. Participants also showed profound changes in behavior, attitudes, and interests, indicative of the potential for psilocybin to catalyze significant personal growth and development.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This study highlights the transformative potential of psilocybin experiences and their relevance to psychotherapeutic practices. By employing phenomenological methods, we offer a structured understanding of these states, which could be used in future to provide guidance for their integration into therapy by giving a better insight into psychedelic experience.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fpsyg.2025.1455902","type":"journal-article","created":{"date-parts":[[2025,4,25]],"date-time":"2025-04-25T01:25:07Z","timestamp":1745544307000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":12,"title":["The phenomenology of psilocybin: transformative insights for research and clinical practice"],"prefix":"10.3389","volume":"16","author":[{"given":"Antonio","family":"Metastasio","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth","family":"Prevete","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofia","family":"Venturini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Garofalo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatrice","family":"Cecconello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"De Pisapia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ornella","family":"Corazza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,4,25]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1037\/adb0000935","article-title":"Reports of self-compassion and affect regulation in psilocybin-assisted therapy for alcohol use disorder: an interpretive phenomenological analysis","volume":"38","author":"Agin-Liebes","year":"2024","journal-title":"Psychol. Addict. Behav."},{"key":"ref2","doi-asserted-by":"publisher","first-page":"2214","DOI":"10.1038\/s41598-020-59282-y","article-title":"Emotions and brain function are altered up to one month after a single high dose of psilocybin","volume":"10","author":"Barrett","year":"2020","journal-title":"Sci. Rep."},{"key":"ref3","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1177\/0022167817706884","article-title":"Patient experiences of psilocybin-assisted psychotherapy: an interpretative phenomenological analysis","volume":"57","author":"Belser","year":"2017","journal-title":"J. Humanist. Psychol."},{"key":"ref4","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1177\/0269881114565144","article-title":"Psilocybin-assisted treatment for alcohol dependence: a proof-of-concept study","volume":"29","author":"Bogenschutz","year":"2015","journal-title":"J. Psychopharmacol."},{"key":"ref5","doi-asserted-by":"publisher","first-page":"2929","DOI":"10.1038\/s41598-024-53188-9","article-title":"Patient perspectives and experiences with psilocybin treatment for treatment-resistant depression: a qualitative study","volume":"14","author":"Breeksema","year":"2024","journal-title":"Sci. Rep."},{"key":"ref6","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1007\/s00213-017-4771-x","article-title":"Psilocybin with psychological support for treatment-resistant depression: six-month follow-up","volume":"235","author":"Carhart-Harris","year":"2018","journal-title":"Psychopharmacology"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1016\/S2215-0366(16)30065-7","article-title":"Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study","volume":"3","author":"Carhart-Harris","year":"2016","journal-title":"Lancet Psychiatry"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"460","DOI":"10.3389\/fpsyt.2020.00460","article-title":"Novel psychoactive substances in custodial settings: a mixed method investigation on the experiences of people in prison and professionals working with them","volume":"11","author":"Corazza","year":"2020","journal-title":"Front. Psych."},{"key":"ref9","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1001\/jamapsychiatry.2020.3285","article-title":"Effects of psilocybin-assisted therapy on major depressive disorder: a randomized clinical trial","volume":"78","author":"Davis","year":"2021","journal-title":"JAMA Psychiatry"},{"key":"ref10","first-page":"1","article-title":"Pahnke\u2019s \u201cgood Friday experiment\u201d: a long-term follow-up and methodological critique","volume":"23","author":"Doblin","year":"1991","journal-title":"J. Transpers. Psychol."},{"key":"ref11","doi-asserted-by":"publisher","first-page":"112749","DOI":"10.1016\/j.psychres.2020.112749","article-title":"The experimental effects of psilocybin on symptoms of anxiety and depression: a meta-analysis","volume":"284","author":"Goldberg","year":"2020","journal-title":"Psychiatry Res."},{"key":"ref12","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1177\/0269881116675513","article-title":"Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: a randomized double-blind trial","volume":"30","author":"Griffiths","year":"2016","journal-title":"J. Psychopharmacol."},{"key":"ref13","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1177\/0269881117731279","article-title":"Psilocybin-occasioned mystical-type experience in combination with meditation and other spiritual practices produces enduring positive changes in psychological functioning and in trait measures of prosocial attitudes and behaviors","volume":"32","author":"Griffiths","year":"2018","journal-title":"J. Psychopharmacol."},{"key":"ref14","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1177\/0269881108094300","article-title":"Mystical-type experiences occasioned by psilocybin mediate the attribution of personal meaning and spiritual significance 14 months later","volume":"22","author":"Griffiths","year":"2008","journal-title":"J. Psychopharmacol."},{"key":"ref15","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1007\/s00213-006-0457-5","article-title":"Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance","volume":"187","author":"Griffiths","year":"2006","journal-title":"Psychopharmacology"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1177\/0269881114550935","article-title":"Back to the future: a return to psychedelic treatment models for addiction","volume":"28","author":"Hendricks","year":"2014","journal-title":"J. Psychopharmacol."},{"key":"ref17","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1111\/phpr.12378","article-title":"Philosophical analysis: the concept grounding view","volume":"97","author":"Horvath","year":"2018","journal-title":"Philos. Phenomenol. Res."},{"key":"ref18","author":"Houot","year":"2021"},{"key":"ref19","first-page":"1157","article-title":"The impact of psilocybin on visual perception and spatial orientation - neuropsychological approach","volume":"47","author":"Jastrzebski","year":"2013","journal-title":"Psychiatr. Pol."},{"key":"ref20","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1177\/0269881114548296","article-title":"Pilot study of the 5-HT2AR agonist psilocybin in the treatment of tobacco addiction","volume":"28","author":"Johnson","year":"2014","journal-title":"J. Psychopharmacol."},{"key":"ref21","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1007\/s13311-017-0542-y","article-title":"Potential therapeutic effects of psilocybin","volume":"14","author":"Johnson","year":"2017","journal-title":"Neurotherapeutics"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.pharmthera.2018.11.010","article-title":"Classic psychedelics: an integrative review of epidemiology, therapeutics, mystical experience, and brain network function","volume":"197","author":"Johnson","year":"2019","journal-title":"Pharmacol. Ther."},{"key":"ref23","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s12954-017-0138-1","article-title":"Assessing the experience of using synthetic cannabinoids by means of interpretative phenomenological analysis","volume":"14","author":"Kassai","year":"2017","journal-title":"Harm Reduct. J."},{"key":"ref24","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1016\/j.biopsych.2014.04.010","article-title":"Psilocybin-induced decrease in amygdala reactivity correlates with enhanced positive mood in healthy volunteers","volume":"78","author":"Kraehenmann","year":"2015","journal-title":"Biol. Psychiatry"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1093\/nc\/nix016","article-title":"Self unbound: ego dissolution in psychedelic experience","volume":"2017","author":"Letheby","year":"2017","journal-title":"Neurosci. Conscious."},{"key":"ref26","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1177\/0269881111420188","article-title":"Mystical experiences occasioned by the hallucinogen psilocybin lead to increases in the personality domain of openness","volume":"25","author":"MacLean","year":"2011","journal-title":"J. Psychopharmacol."},{"key":"ref27","doi-asserted-by":"publisher","first-page":"2003","DOI":"10.1038\/s41386-020-0718-8","article-title":"Me, myself, bye: regional alterations in glutamate and the experience of ego dissolution with psilocybin","volume":"45","author":"Mason","year":"2020","journal-title":"Neuropsychopharmacology"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"841648","DOI":"10.3389\/fphar.2022.841648","article-title":"Psilocybin-induced mystical-type experiences are related to persisting positive effects: a quantitative and qualitative report","volume":"13","author":"McCulloch","year":"2022","journal-title":"Front. Pharmacol."},{"key":"ref29","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1177\/02698811211026454","article-title":"Lasting effects of a single psilocybin dose on resting-state functional connectivity in healthy individuals","volume":"36","author":"McCulloch","year":"2022","journal-title":"J. Psychopharmacol."},{"key":"ref30","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1177\/00048674221139962","article-title":"Understanding subjective experience in psychedelic-assisted psychotherapy: the need for phenomenology","volume":"57","author":"Miceli McMillan","year":"2023","journal-title":"Aust. N. Z. J. Psychiatry"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1016\/j.beth.2019.05.005","article-title":"Changes in empathy mediate the effects of cognitive-behavioral group therapy but not mindfulness-based stress reduction for social anxiety disorder","volume":"50","author":"Morrison","year":"2019","journal-title":"Behav. Ther."},{"key":"ref32","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1080\/14780887.2020.1854404","article-title":"Achieving excellence in interpretative phenomenological analysis (IPA): four markers of high quality","volume":"18","author":"Nizza","year":"2021","journal-title":"Qual. Res. Psychol."},{"key":"ref33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1017\/S0017816000027577","article-title":"The psychedelic mystical experience in the human encounter with death","volume":"62","author":"Pahnke","year":"1969","journal-title":"Harv. Theol. Rev."},{"key":"ref34","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1007\/7854_2016_459","article-title":"Phenomenology, structure, and dynamic of psychedelic states","volume":"36","author":"Preller","year":"2018","journal-title":"Curr. Top. Behav. Neurosci."},{"key":"ref35","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.neuropharm.2017.12.041","article-title":"Increased amygdala responses to emotional faces after psilocybin for treatment-resistant depression","volume":"142","author":"Roseman","year":"2018","journal-title":"Neuropharmacology"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.neuroimage.2019.04.009","article-title":"Psilocybin-assisted mindfulness training modulates self-consciousness and brain default mode network connectivity with lasting effects","volume":"196","author":"Smigielski","year":"2019","journal-title":"NeuroImage"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"11241","DOI":"10.1177\/20503245221124117","article-title":"An interpretative phenomenological analysis of the use of psilocybin by veterans with symptoms of trauma","volume":"8","author":"Smith","year":"2022","journal-title":"Drug Sci. Policy Law"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1159\/000500272","article-title":"The PHD method for psychotherapy: integrating phenomenology, hermeneutics, and psychodynamics","volume":"52","author":"Stanghellini","year":"2019","journal-title":"Psychopathology"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1124\/pharmrev.121.000508","article-title":"Neural mechanisms and psychology of psychedelic Ego dissolution","volume":"74","author":"Stoliker","year":"2022","journal-title":"Pharmacol. Rev."},{"key":"ref40","doi-asserted-by":"publisher","first-page":"e30800","DOI":"10.1371\/journal.pone.0030800","article-title":"Prediction of psilocybin response in healthy volunteers","volume":"7","author":"Studerus","year":"2012","journal-title":"PLoS One"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"7","DOI":"10.12663\/PSYHUNG.2.2014.2.1","article-title":"Attila Szabo, Lajos Horvath and Csaba Szummer: phenomenology and altered states of consciousness: a new framework for analysis? Psychologia Hungarica Caroliensis, 2014\/2: 7-29, ISSN 2064-2504","volume":"1","author":"Szabo","year":"2014","journal-title":"Psychol. Hung. Caroliensis"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1556\/2054.01.2017.006","article-title":"The hyperassociative mind: The psychedelic experience and Merleau-Ponty\u2019s \u201cwild being\u201d","volume":"1","author":"Szummer","year":"2017","journal-title":"J. Psychedelic Stud."},{"key":"ref43","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1002\/da.23071","article-title":"COVID stress syndrome: concept, structure, and correlates","volume":"37","author":"Taylor","year":"2020","journal-title":"Depress. Anxiety"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"117","DOI":"10.2174\/1874473708666150107120930","article-title":"A qualitative report on the subjective experience of intravenous psilocybin administered in an FMRI environment","volume":"7","author":"Turton","year":"2014","journal-title":"Curr. Drug Abuse Rev."},{"key":"ref45","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1055\/a-1721-2914","article-title":"Classic psychedelic drugs: update on biological mechanisms","volume":"55","author":"Vollenweider","year":"2022","journal-title":"Pharmacopsychiatry"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1177\/0269881106065859","article-title":"Effects of psilocybin on time perception and temporal control of behaviour in humans","volume":"21","author":"Wittmann","year":"2007","journal-title":"J. Psychopharmacol."},{"key":"ref47","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1021\/acsptsci.0c00194","article-title":"The subjective effects of psychedelics are necessary for their enduring therapeutic effects","volume":"4","author":"Yaden","year":"2021","journal-title":"ACS Pharmacol. Transl. Sci."}],"container-title":["Frontiers in Psychology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpsyg.2025.1455902\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,25]],"date-time":"2025-04-25T01:25:08Z","timestamp":1745544308000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpsyg.2025.1455902\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,25]]},"references-count":47,"alternative-id":["10.3389\/fpsyg.2025.1455902"],"URL":"https:\/\/doi.org\/10.3389\/fpsyg.2025.1455902","relation":{},"ISSN":["1664-1078"],"issn-type":[{"value":"1664-1078","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,25]]},"article-number":"1455902"}}